DK193589A - Hidtil ukendt polypeptid og fremgangsmaade til dets fremstilling - Google Patents

Hidtil ukendt polypeptid og fremgangsmaade til dets fremstilling

Info

Publication number: DK193589A
Authority: DK; Denmark
Prior art keywords: preparing; same; procedures; preparation; unknown polypeptide
Prior art date: 1987-08-21

Application number

DK193589A

Other languages

Danish (da)

English (en)

Other versions

DK193589D0 (da

Inventor

Takanori Nakamura

Sadaaki Iwanaga

Motonori Ohno

Kyosuke Miyazaki

Original Assignee

Seikagaku Kogyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-08-21

Filing date

1989-04-20

Publication date

1989-06-16

1989-04-20 Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd

1989-04-20 Publication of DK193589D0 publication Critical patent/DK193589D0/da

1989-06-16 Publication of DK193589A publication Critical patent/DK193589A/da

Links

238000000034 method Methods 0.000 title abstract 3
229920001184 polypeptide Polymers 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 3
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 2
239000002158 endotoxin Substances 0.000 abstract 2
OIXLLKLZKCBCPS-RZVRUWJTSA-N (2s)-2-azanyl-5-[bis(azanyl)methylideneamino]pentanoic acid Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.OC(=O)[C@@H](N)CCCNC(N)=N OIXLLKLZKCBCPS-RZVRUWJTSA-N 0.000 abstract 1
208000035143 Bacterial infection Diseases 0.000 abstract 1
LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 abstract 1
239000004471 Glycine Substances 0.000 abstract 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
239000004472 Lysine Substances 0.000 abstract 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
125000003277 amino group Chemical group 0.000 abstract 1
208000022362 bacterial infectious disease Diseases 0.000 abstract 1
229960003067 cystine Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
229960000310 isoleucine Drugs 0.000 abstract 1
229920006008 lipopolysaccharide Polymers 0.000 abstract 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
239000004474 valine Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK193589A 1987-08-21 1989-04-20 Hidtil ukendt polypeptid og fremgangsmaade til dets fremstilling DK193589A (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP20625887		1987-08-21
PCT/JP1988/000823 WO1989001492A1 (fr)	1987-08-21	1988-08-19	Nouveau polypeptide et procede de prepration

Publications (2)

Publication Number	Publication Date
DK193589D0 DK193589D0 (da)	1989-04-20
DK193589A true DK193589A (da)	1989-06-16

Family

ID=16520353

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK193589A DK193589A (da)	1987-08-21	1989-04-20	Hidtil ukendt polypeptid og fremgangsmaade til dets fremstilling

Country Status (13)

Country	Link
US (2)	US5068314A (fr)
EP (1)	EP0343248B1 (fr)
JP (1)	JP2710653B2 (fr)
KR (1)	KR970001811B1 (fr)
CN (1)	CN1031193C (fr)
AT (1)	ATE88480T1 (fr)
AU (1)	AU642089B2 (fr)
CA (2)	CA1337781C (fr)
DE (1)	DE3880481T2 (fr)
DK (1)	DK193589A (fr)
FI (1)	FI92708C (fr)
NO (2)	NO175372C (fr)
WO (1)	WO1989001492A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1337781C (fr) *	1987-08-21	1995-12-19	Takanori Nakamura	Polypeptide provenant de la limule, manifestant de l'affinite pour les lipopolysaccharides; methode de preparation
US5594113A (en) *	1988-06-23	1997-01-14	Associates Of Cape Cod, Inc.	Endotoxin binding and neutralizing protein and uses thereof
FI922044A0 (fi) *	1990-09-11	1992-05-06	Seikagaku Kogyo Co Ltd	Ny polypeptid och daerav framstaelld hiv-medicin.
EP0549102B1 (fr) *	1991-12-25	1996-07-03	Maruha Corporation	Réactifs et procédés pour déterminer des Beta-Glucanes
JP3361830B2 (ja) *	1992-03-30	2003-01-07	生化学工業株式会社	抗菌性組成物及びそれを有効成分とする薬剤
EP0572688B1 (fr) *	1992-05-30	1997-05-07	Predrag Dr.Sc. Sikiric	Peptides de BPC, leur préparation et utilisation
JP3402476B2 (ja) *	1992-08-24	2003-05-06	生化学工業株式会社	リポ多糖結合性タンパク質及びその製造法
CA2112776C (fr) *	1993-01-21	2002-11-12	Masakazu Tsuchiya	Methode pour inhiber l'activite d'une endotoxine
WO1995005393A2 (fr)	1993-08-18	1995-02-23	Morphosys Gesellschaft Für Proteinoptimierung Mbh	Peptides liant et neturalisant les lipopolysaccharides
JPH08504837A (ja) *	1993-10-14	1996-05-28	生化学工業株式会社	新規ポリペプチドおよびこれから調製される抗ｈｉｖ剤
KR100257310B1 (ko) *	1996-12-21	2000-05-15	정몽규	트렁크 리드 개폐장치
US6011066A (en) *	1998-02-02	2000-01-04	Veterans General Hospital-Taipei	Method for treating septic shock
CN100389140C (zh) *	2006-05-12	2008-05-21	北京理工大学	由聚肽-b-聚四氢呋喃-b-聚肽三嵌段共聚物制备纳米及微米级自组装体的方法
WO2011008863A2 (fr) *	2009-07-14	2011-01-20	Lucia Irene Gonzalez	Peptides stéréoisomères et leurs conjugués polymères pour infection par le vih
CN108623659B (zh) *	2018-03-17	2021-09-14	中国海洋大学	一种氨基酸全部选用d型氨基酸的抗菌肽合成方法
WO2021183061A1 (fr) *	2020-03-13	2021-09-16	Vet Products Research And Innovation Center Company Limited	Peptides antimicrobiens pour l'inhibition de micro-organismes pathogènes dans les voies digestives et respiratoires chez l'animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4663435A (en) *	1982-12-06	1987-05-05	Merck & Co., Inc.	Bridged cyclic hexapeptide somatostatin analogs
CA1337781C (fr) *	1987-08-21	1995-12-19	Takanori Nakamura	Polypeptide provenant de la limule, manifestant de l'affinite pour les lipopolysaccharides; methode de preparation

1988
- 1988-08-18 CA CA000575083A patent/CA1337781C/fr not_active Expired - Fee Related
- 1988-08-19 DE DE8888907358T patent/DE3880481T2/de not_active Expired - Fee Related
- 1988-08-19 EP EP88907358A patent/EP0343248B1/fr not_active Expired - Lifetime
- 1988-08-19 JP JP63505336A patent/JP2710653B2/ja not_active Expired - Lifetime
- 1988-08-19 AT AT88907358T patent/ATE88480T1/de not_active IP Right Cessation
- 1988-08-19 KR KR1019890700677A patent/KR970001811B1/ko not_active Expired - Fee Related
- 1988-08-19 US US07/348,487 patent/US5068314A/en not_active Expired - Fee Related
- 1988-08-19 WO PCT/JP1988/000823 patent/WO1989001492A1/fr not_active Ceased
- 1988-08-20 CN CN88106207A patent/CN1031193C/zh not_active Expired - Fee Related
1989
- 1989-04-18 NO NO891572A patent/NO175372C/no not_active IP Right Cessation
- 1989-04-19 FI FI891873A patent/FI92708C/fi not_active IP Right Cessation
- 1989-04-20 DK DK193589A patent/DK193589A/da not_active Application Discontinuation
1991
- 1991-12-12 CA CA000616257A patent/CA1337782C/fr not_active Expired - Fee Related
1992
- 1992-05-20 AU AU17028/92A patent/AU642089B2/en not_active Ceased
- 1992-08-07 US US07/926,965 patent/US5416194A/en not_active Expired - Fee Related
1994
- 1994-01-10 NO NO940078A patent/NO178663C/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE88480T1 (de)	1993-05-15
JP2710653B2 (ja)	1998-02-10
NO891572L (no)	1989-05-09
DE3880481D1 (de)	1993-05-27
US5068314A (en)	1991-11-26
CN1031379A (zh)	1989-03-01
AU642089B2 (en)	1993-10-07
CA1337781C (fr)	1995-12-19
NO178663C (no)	1996-05-08
NO891572D0 (no)	1989-04-18
FI92708C (fi)	1994-12-27
EP0343248A1 (fr)	1989-11-29
NO175372C (no)	1994-10-05
NO178663B (no)	1996-01-29
KR890701624A (ko)	1989-12-21
WO1989001492A1 (fr)	1989-02-23
AU1702892A (en)	1992-07-16
NO175372B (no)	1994-06-27
AU620345B2 (en)	1992-02-20
FI891873A0 (fi)	1989-04-19
AU2311388A (en)	1989-03-09
US5416194A (en)	1995-05-16
FI891873A7 (fi)	1989-04-19
FI92708B (fi)	1994-09-15
NO940078D0 (no)	1994-01-10
JPH02500194A (ja)	1990-01-25
CA1337782C (fr)	1995-12-19
EP0343248B1 (fr)	1993-04-21
NO940078L (no)	1989-05-09
DK193589D0 (da)	1989-04-20
DE3880481T2 (de)	1993-09-09
KR970001811B1 (ko)	1997-02-15
CN1031193C (zh)	1996-03-06

Legal Events

Date	Code	Title	Description
2002-05-21	AHS	Application shelved for other reasons than non-payment

Publication	Publication Date	Title
DK193589A (da)	1989-06-16	Hidtil ukendt polypeptid og fremgangsmaade til dets fremstilling
KR840005080A (ko)	1984-11-03	디노르핀 아미드 동족체의 제조방법
AU633913B2 (en)	1993-02-11	Novel tnf-inhibit proteins and their preparation
AU4188789A (en)	1989-10-05	Urethane-protected amino acid-n-carboxyanhydrides
CA2187083A1 (fr)	1995-10-19	Fragment peptidique de la proteine g du virus respiratoire syncytial, agent immunogene, composition pharmaceutique le contenant et procede de preparation
KR960031602A (ko)	1996-09-17	유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조 방법
KR910016343A (ko)	1991-11-05	사람 파필로마바이러스(hpv) 16 단백질의 혈청반응성 에피토프
ATE162201T1 (de)	1998-01-15	Cnp-gen und vorläuferprotein aus schwein
Ozols	1970	Amino acid sequence of rabbit liver microsomal cytochrome b5
GB1394846A (en)	1975-05-21	Polypeptides
DK0573538T3 (da)	1995-06-26	Peptider til behandling
AU1599892A (en)	1992-11-05	Novel polypeptides with affinity to lipopolysaccharides and their uses
Kuromizu et al.	1986	Reexamination of the primary structure of an antitumor protein, neocarzinostatin
TAKAGI et al.	1983	Amino acid sequence of troponin C obtained from ascidian (Halocynthia roretzi) body wall muscle
NO942360L (no)	1994-10-05	Vaksine og polypeptider som er nyttige for denne
RU94024392A (ru)	1996-05-20	Минерально-аминокислотный концентрат
AU6393990A (en)	1991-04-18	Hiv related peptides
EP0361956A3 (fr)	1991-07-10	Expression augmentée de protéines recombinantes à faible poids moléculaire
KOTAKI et al.	1962	Studies on Insulin: IV. On the Amino Acid Composition of the Glvcyl Chain of Bonito Insulin-I
Margalit et al.	1978	Subunit structure of canavalin
FI961398L (fi)	1996-03-27	Menetelmä terapeuttisesti käyttökelpoisen peptidin valmistamiseksi
RU97114945A (ru)	1999-07-20	Белки против ожирения
TW370615B (en)	1999-09-21	Method and kit for simultaneously detecting antibodies of HIV-1 and HIV-2
UA28084C2 (uk)	2000-10-16	Протипухлинний засіб, виділений з слизової кишечника, спосіб його виділення
TH4070A (th)	1987-04-01	ลำดับ dna ที่มีรหัสของเซอร์เฟสแอนติเจนโปรตีน p31 ที่ดัดแปลงของไวรัสเฮพพาทิทิส บี